CapsoVision Inc. Announces FDA Enforcement Discretion for At-Home Capsule Endoscopy Administration of CapsoCam Plus during COVID-19
The labeling addendum permits a fully remote capsule endoscopy procedure for eligible patients, eliminating the need for in-person interaction between clinic staff and patient.
- The labeling addendum permits a fully remote capsule endoscopy procedure for eligible patients, eliminating the need for in-person interaction between clinic staff and patient.
- "CapsoVision's advanced capsule technology delivers high-quality diagnostic images without creating a risk of in-person exposure to COVID-19," stated Johnny Wang, President and CTO.
- The CapsoCam Plus video capsule system is intended for the visualization of the small bowel mucosa in adults.
- CapsoVision currently offers the CapsoCam Plus capsule endoscopy system in over 70 countries, and CapsoCloud and CapsoPro services in the USA.